Melanie F Myers1,2, Xue Zhang1, Brooke McLaughlin1,2, Diane Kissell1, Cassandra L Perry3, Matthew Veerkamp4, Kejian Zhang1, Ingrid A Holm5,6, Cynthia A Prows1,7. 1. Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. 2. College of Medicine, Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45267, USA. 3. Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA. 4. Center for Autoimmune Genomics & Etiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. 5. Division of Genetics & Genomics & The Manton Center for Orphan Disease Research, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, USA. 6. Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. 7. Division of Patient Services, Department of Clinical Shared Services, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Abstract
AIM: To determine parents' use of their children's CYP2D6 research result. We hypothesized that perceived utility, likelihood of sharing and actual sharing of results would differ between parents with children previously exposed (cases) or unexposed (controls) to opioids. METHODS: We returned results by phone (baseline). We surveyed parents about perceived utility and likelihood of sharing their child's research result at baseline, and actual sharing at 3 and 12 months. RESULTS: Cases were more likely than controls to agree that they (p = 0.022) and the doctors (p = 0.041) could use the results to care for their child, to report higher likelihood of sharing (p = 0.042) and to actually share results with the child's doctor (p = 0.026). CONCLUSION: Prior opioid exposure influenced perceived clinical utility and sharing behaviors.
AIM: To determine parents' use of their children's CYP2D6 research result. We hypothesized that perceived utility, likelihood of sharing and actual sharing of results would differ between parents with children previously exposed (cases) or unexposed (controls) to opioids. METHODS: We returned results by phone (baseline). We surveyed parents about perceived utility and likelihood of sharing their child's research result at baseline, and actual sharing at 3 and 12 months. RESULTS: Cases were more likely than controls to agree that they (p = 0.022) and the doctors (p = 0.041) could use the results to care for their child, to report higher likelihood of sharing (p = 0.042) and to actually share results with the child's doctor (p = 0.026). CONCLUSION: Prior opioid exposure influenced perceived clinical utility and sharing behaviors.
Entities:
Keywords:
CYD2D6; clinic utility; pediatric; pharmacogenetics testing; return of results; sharing of results
Authors: Agatha M Gallo; Denise Angst; Kathleen A Knafl; Emily Hadley; Carrol Smith Journal: J Pediatr Health Care Date: 2005 Sep-Oct Impact factor: 1.812
Authors: Shanna K O'Connor; Stefanie P Ferreri; Natasha M Michaels; Rebecca W Chater; Anthony J Viera; Hawazin Faruki; Howard L McLeod; Mary Roederer Journal: J Am Pharm Assoc (2003) Date: 2012
Authors: Adam S Gordon; Robert S Fulton; Xiang Qin; Elaine R Mardis; Deborah A Nickerson; Steve Scherer Journal: Pharmacogenet Genomics Date: 2016-04 Impact factor: 2.089
Authors: J O'Daniel; J Lucas; P Deverka; D Ermentrout; G Silvey; D F Lobach; S B Haga Journal: Public Health Genomics Date: 2009-05-04 Impact factor: 2.000
Authors: Sarah S Kalia; Kathy Adelman; Sherri J Bale; Wendy K Chung; Christine Eng; James P Evans; Gail E Herman; Sophia B Hufnagel; Teri E Klein; Bruce R Korf; Kent D McKelvey; Kelly E Ormond; C Sue Richards; Christopher N Vlangos; Michael Watson; Christa L Martin; David T Miller Journal: Genet Med Date: 2016-11-17 Impact factor: 8.822
Authors: Kristi D Graves; Pamela S Sinicrope; Mary Jane Esplen; Susan K Peterson; Christi A Patten; Jan Lowery; Frank A Sinicrope; Sandra K Nigon; Joyce Borgen; Sherri Sheinfeld Gorin; Louise A Keogh; Noralane M Lindor Journal: Genet Med Date: 2013-10-03 Impact factor: 8.822
Authors: Erin D Harris; Sonja I Ziniel; Jonathan G Amatruda; Catherine M Clinton; Sarah K Savage; Patrick L Taylor; Noelle L Huntington; Robert C Green; Ingrid A Holm Journal: Genet Med Date: 2012-01-26 Impact factor: 8.822